Journals / Bezmiâlem Science / 2018 / Cilt: 6 - Sayı: 3

Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus Treated with Double Filtration Plasmapheresis

Diffüz Alveoler Hemoraji'li Sistemik Lupus Eritematozus Olgusunda Double Filtrasyon Plazmaferez

Pages
228–32
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, DFPP therapy should be considered for thetreatment of diffuse alveolar hemorrhage, particularly in patientsof systemic lupus erythematosus with lupus nephritis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diffuse alveolar hemorrhage is a rare and life-threatening com-plication developed in systemic lupus erythematosus (SLE).
📊
Key Findings & Data:The patient participatedin a plasmapheresis program, and double filtration plasmapher-esis (DFPP) therapy was performed for six sessions in 6 days.Soon after the initiation of DFPP, she recovered with resolutionof the radiological changes within 6 days and was successfullyextubated.
💡
Conclusion & Impact:Thus, DFPP therapy should be considered for thetreatment of diffuse alveolar hemorrhage, particularly in patientsof systemic lupus erythematosus with lupus nephritis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diffuse alveolar hemorrhage is a rare and life-threatening com-plication developed in systemic lupus erythematosus (SLE). Wereport a case of diffuse alveolar hemorrhage in a patient withlupus nephritis. The patient presented with acute respiratory andrenal failure. Therefore, she was assessed as an activation of sys-temic lupus erythematosus. Despite pulse methylprednisolone,immunosuppressant drugs, and intravenous immunoglobulin(IVIG) therapy, the disease progressed. The patient participatedin a plasmapheresis program, and double filtration plasmapher-esis (DFPP) therapy was performed for six sessions in 6 days.Soon after the initiation of DFPP, she recovered with resolutionof the radiological changes within 6 days and was successfullyextubated. Thus, DFPP therapy should be considered for thetreatment of diffuse alveolar hemorrhage, particularly in patientsof systemic lupus erythematosus with lupus nephritis.

Özet

Diffüz alveoler hemoraji, Sistemik Lupus Eritematozus (SLE) tanılı hastalarda nadir görülen ve katastrofik seyir gösteren bir klinik süreçtir. Olguda lupus nefriti tanısı ile takip edilirken dif- füz alveoler hemoraji gelişen hasta anlatıldı. Ani gelişen nefes darlığı ile hastaneye başvuran hastada akut solunum yetmezliği ve böbrek yetmezliği bulguları lupus alevlenmesi olarak değer- lendirildi. Pulse metilprednizolon, immunsüpresan tedavi ve intravenöz immunglobulin tedavisine rağmen iyileşme görül- medi. Double Filtrasyon Plazmaferez uygulaması ile altı seans sonunda alveoler hemoraji bulgularının klinik ve radyolojik ola- rak düzeldiği görüldü. Hasta altıncı gün sonunda ekstübe edildi. Olgumuz özellikle diffüz alveoler hemoraji ile birliktelik göste- ren sistemik lupus eritematozus hastalarında tedavide double filtrasyon plazmaferez kullanımının akılda tutulması açısından önem taşımaktadır.

🔖

Cite This Article

KAZANCIOĞLU, R., ÇETİN, G., TURGUT, S., KARATOPRAK, C., ÖZKAN, T. (2022). Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus Treated with Double Filtration Plasmapheresis. Bezmiâlem Science, Cilt: 6 - Sayı: 3, 228–32. https://ajindex.com/articles/464148

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemor- rhage in systemic lupus erythematosus: presentation and man- agement. Chest 2000; 118: 1083-90. [CrossRef ] Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest 2010; 137: 1164-71. [CrossRef ] Shen M, Zeng X, Tian X, Zhang F, Zeng X, Zhang X, et al. Dif- fuse alveolar hemorrhage in systemic lupus erythematosus: a ret- rospective study in China. Lupus 2010; 19: 1326-30. [CrossRef ] Claridge S, Das P, Dorling A, Robson MG. Plasmapheresis as rescue therapy for systemic lupus erthyematosus-associ- ated diffuse alveolar haemorrhage. BMJ Case Rep 2011: p. bcr0220113893. [CrossRef ] Lumlertgul D, Suteeka Y, Tumpong S, Bunnachak D, Boonkaew S. Double filtration plasmapheresis in different diseases in Thai- land. Ther Apher Dial 2013; 17: 99-116. [CrossRef ] Park MS. Diffuse alveolar hemorrhage. Tuberc Respir Dis (Seoul) 2013; 74: 151-62. [CrossRef ] Virdi RP, Bashir A, Shahzad G, Iqbal J, Mejia JO. Diffuse alveo- lar hemorrhage: a rare life-threatening condition in systemic lupus erythematosus. Case Rep Pulmonol 2012: 836017. [CrossRef] Shemin D, Briggs D, Greenan M. Complications of therapeu- tic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher 2007; 22: 270-6. [CrossRef ] Iwatani H, Uzu T, Kakihara M, Nakayama Y, Kanasaki K, Yamato M, et al., A case of Wegener’s granulomatosis with pulmonary bleeding successfully treated with double filtra- tion plasmapheresis (DFPP). Clin Exp Nephrol 2004; 8: 369-74. [CrossRef ] Lyu RK, Chen WH, Hsieh ST. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syn- drome. Ther Apher 2002; 6: 163-6. [CrossRef ]